Compare Stocks → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:NARINASDAQ:UPST Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNARIInari Medical$38.07-0.3%$45.68$36.73▼$71.85$2.21B0.841.13 million shs873,494 shsUPSTUpstart$22.83-1.3%$25.00$11.93▼$72.58$2.03B1.943.67 million shs2.86 million shs(Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNARIInari Medical-0.29%-1.48%-17.44%-31.87%-44.53%UPSTUpstart-1.25%+2.33%-14.11%-30.01%+59.54%“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNARIInari Medical2.6405 of 5 stars3.33.00.00.01.93.30.6UPSTUpstart2.7398 of 5 stars1.82.00.02.71.93.30.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNARIInari Medical2.67Moderate Buy$73.7193.63% UpsideUPSTUpstart1.64Reduce$26.0013.89% UpsideCurrent Analyst RatingsLatest UPST and NARI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/17/2024UPSTUpstartJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform4/12/2024NARIInari MedicalCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$75.004/4/2024UPSTUpstartBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageUnderperform$22.003/22/2024NARIInari MedicalTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$61.00 ➝ $52.003/19/2024UPSTUpstartPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$28.003/6/2024NARIInari MedicalNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$72.002/29/2024NARIInari MedicalTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold$63.00 ➝ $61.002/29/2024NARIInari MedicalNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$72.002/29/2024NARIInari MedicalCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$79.00 ➝ $75.002/29/2024NARIInari MedicalPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$85.00 ➝ $55.002/14/2024UPSTUpstartJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$26.00 ➝ $24.00(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNARIInari Medical$493.63M4.47$0.09 per share420.87$8.07 per share4.72UPSTUpstart$513.56M3.90N/AN/A$7.47 per share3.06Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNARIInari Medical-$1.64M-$0.03N/A102.89N/A-0.33%1.23%0.97%4/30/2024 (Confirmed)UPSTUpstart-$240.13M-$2.90N/AN/AN/A-46.76%-35.47%-11.85%5/7/2024 (Confirmed)Latest UPST and NARI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2024N/AUPSTUpstart-$0.3840N/A+$0.3840N/AN/AN/A 4/30/2024N/ANARIInari Medical-$0.16N/A+$0.16N/AN/AN/A 2/28/202412/31/2023NARIInari Medical$0.01-$0.08-$0.09$0.18$131.82 million$132.10 million 2/13/2024Q4 2023UPSTUpstart-$0.56-$0.51+$0.05-$0.52$135.28 million$140.31 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNARIInari MedicalN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNARIInari MedicalN/A3.092.52UPSTUpstartN/A0.390.39OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNARIInari Medical90.98%UPSTUpstart63.01%Insider OwnershipCompanyInsider OwnershipNARIInari Medical10.60%UPSTUpstart18.06%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableNARIInari Medical1,30057.96 million51.82 millionOptionableUPSTUpstart1,38887.81 million71.95 millionOptionableUPST and NARI HeadlinesSourceHeadlineUpstart Launches Recognized Customer Personalizationbusinesswire.com - April 25 at 9:00 AMUpstart Holdings, Inc. (NASDAQ:UPST) Given Average Rating of "Reduce" by Brokeragesamericanbankingnews.com - April 25 at 1:38 AMUpstart Holdings, Inc. (UPST) Outperforms Broader Market: What You Need to Knowzacks.com - April 24 at 7:16 PMForget Upstart, These Unstoppable Stocks Are Better Buysfool.com - April 24 at 6:15 AMUpstart: A Coiled Spring Waiting For Lower Interest Rates (Rating Upgrade)seekingalpha.com - April 23 at 8:06 AMNio Stock’s Grim Reality: 3 Brutal Truths Dooming the Once-Promising EV Upstartinvestorplace.com - April 22 at 7:04 AMLoad Up on These 3 Student Loan Stock Plays if Biden Beats the Courtsinvestorplace.com - April 18 at 3:26 PMUpstart (UPST) to Enhance PriorityONE's Digital Lending Systemzacks.com - April 18 at 12:36 PMUpstart (NASDAQ:UPST) Receives Market Perform Rating from JMP Securitiesamericanbankingnews.com - April 18 at 5:30 AMPriorityONE Credit Union of Florida Selects Upstart for Personal Lendingbusinesswire.com - April 17 at 9:00 AMUpstart Stock Is Down 94%. Is It Finally Time to Buy?fool.com - April 16 at 8:15 AMUpstart to Report First Quarter 2024 Earnings on May 7, 2024businesswire.com - April 11 at 4:48 PMFormer Upstart Founding Executive, Jeff Keltner, Joins LawFi as Strategic Advisorbusinesswire.com - April 9 at 1:06 PMBearish Blades: 3 Falling Knives to Dodge in 2024investorplace.com - April 8 at 2:45 PMUpstart (UPST) to Install Digital Lending Solution for Kaua'i FCUzacks.com - April 8 at 1:26 PM3 Financial Stocks Short Sellers Are Banking On to Failinvestorplace.com - April 8 at 9:16 AMWarning: This Skyrocketing Stock Has a Hidden Riskfool.com - April 6 at 8:20 AMUpstart Holdings: Lower Volumes Likely To Persistseekingalpha.com - April 4 at 9:12 PMKaua'i Federal Credit Union Selects Upstart for Personal Lendingbusinesswire.com - April 4 at 9:00 AM4 Stocks with Surprisingly Large Short Interestmarketbeat.com - April 3 at 7:45 AM3 Millionaire-Maker AI Stocks to Buy for Multibagger Gainsinvestorplace.com - April 1 at 2:52 PMShorts prevail as SunPower, Volcon, Upstart (UPST) stocks plungeinvezz.com - March 26 at 8:46 AM7 Sorry Financial Stocks to Sell in March While You Still Caninvestorplace.com - March 26 at 6:40 AMUpstart Holdings: Still Too Riskyseekingalpha.com - March 23 at 10:02 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsInari MedicalNASDAQ:NARIInari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.UpstartNASDAQ:UPSTUpstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.